منابع مشابه
5-fluorouracil-induced coronary vasospasm.
BACKGROUND Cardiotoxicity is a rare but well-documented adverse effect of 5-fluorouracil (5-FU). The underlying cause of this side effect of 5-FU is uncertain. METHODS We present a case report of a 63-year-old man treated for metastatic colon cancer who experienced chest pain while being treated with the FOLFIRI regimen. This case report documents coronary artery spasm on catheterization obse...
متن کاملA Case Report of 5-fluorouracil-induced Coronary Artery Vasospasm
Letters RecuRRent venous thRomboses and anti-glomeRulaR basement membRane antibody editor, We wish to record an association between a severe thrombophilic state and the presence of anti-glomerular basement membrane (anti-GBM) antibody. Case Report: An active man aged 41 noticed chest pain, haemoptysis and dark urine after a two-week lecture course late in March 2004. On 18 April he developed he...
متن کامل[Severe coronary vasospasm].
A 50-year-old man, with chronic kidney disease and on dialysis, underwent coronary angiography in the context of acute coronary syndrome, which revealed focal lesions (type A) in the proximal left anterior descending and mid circumflex arteries. Ad-hoc angioplasty was performed on both lesions with direct stenting. An immediate drop in arterial blood pressure was observed and the angiogram show...
متن کاملRituximab-Induced Coronary Vasospasm
Rituximab has improved the treatment of B-cell non-Hodgkin lymphomas. While it is generally well tolerated, serious adverse effects including infusion reactions with hemodynamic compromise and cardiac arrhythmias or ischemia are possible. We report a case of coronary vasospasm occurring during a rituximab infusion in a patient with minimal tumour burden and who had no cardiac risk factors. This...
متن کاملCapecitabine-Induced Coronary Vasospasm
Capecitabine, an oral prodrug of 5-fluorouracil (5-FU), is approved for early-stage and advanced colorectal cancer and metastatic breast cancer. Cardiotoxicity of 5-FU is well described in the literature. However, cardiac adverse effects of capecitabine are poorly described. We report a case of coronary vasospasm induced by capecitabine. A 41-year-old female with metastatic breast cancer presen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: CJC Open
سال: 2019
ISSN: 2589-790X
DOI: 10.1016/j.cjco.2018.11.005